Home » Stocks » ATMS

Artemis Therapeutics, Inc. (ATMS)

Stock Price: $2.41 USD 0.04 (1.65%)
Updated Jun 11, 2021 1:34 PM EDT - Market closed
Market Cap 11.54M
Revenue (ttm) n/a
Net Income (ttm) -136,000
Shares Out 5.15M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $2.41
Previous Close $2.37
Change ($) 0.04
Change (%) 1.65%
Day's Open 2.41
Day's Range 2.41 - 2.41
Day's Volume 1,046
52-Week Range 0.04 - 3.75

News

There are no news available yet.

About ATMS

Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.

Industry
Biotechnology
Stock Exchange
OTCMKTS
Ticker Symbol
ATMS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for ATMS is 3.50, which is an increase of 45.29% from the latest price.

Price Target
$3.50
(45.29% upside)